The 19th Awaji International Forum on Infection and Immunity/The Neo-Virology Symposium
Sep 28 - Oct 1, 2021Online
You can search for presentations in this event.
SearchThe 19th Awaji International Forum on Infection and Immunity/The Neo-Virology Symposium
Sep 28 - Oct 1, 2021Online
You can search for presentations in this event.
SearchSearch Results(94)
[RT-1]Host immunity against mycobacterial infection
○Sho Yamasaki(RIMD, Osaka University, IFReC Osaka University, Suita, Japan)
[RT-2]Targeting regulatory T cells for antigen-specific control of immune responses
○Shimon Sakaguchi(Immunology Frontier Research Center Osaka University, Osaka, Japan)
[RT-3]Can we win the battle against SARS-CoV-2 and prevent SARS-CoV-3?
○Linfa Wang(Duke-NUS Medical School, Singapore)
[S1-1]Virulence factors perforate the pathogen-containing vacuole to generate a find-me signal for efferocytosis
○Hiyoshi Hirotaka1,2, Renee M. Tsolis2, Andreas J. Baumler2(1.Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 2.Department of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, Davis CA, USA)
[S1-2]Xenophagy senses Group A Streptococcus infection through recognizing bacterial surface carbohydrate and Ca2+ elevation caused by bacterial toxin
○Takashi Nozawa, Nakagawa Ichiro(Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
[S1-3]The molecular and structural mechanisms of inactivation of DNA function in mycobacterial dormant persisters
○Sohkichi Matsumoto, Nishiyama Akihito(Department of Bacteriology Niigata University School of Medicine, Niigata, Japan)
[S1-4]Utilization of invertebrate animal model for anti-infective drug discovery
○Atmika Paudel1, Yoshikazu Furuta1, Suresh Panthee2, Hiroshi Hamamoto3, Kazuhisa Sekimizu2, Hideaki Higashi1(1.Division of Infection and Immunity, International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Sapporo, Japan, 2.Drug Discoveries by Silkworm Models, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan, 3.Teikyo University Institute of Medical Mycology, Tokyo, Japan)
[S2-1]MRNA vaccines - what can we learn from Covid-19 vaccination?
○Ooi Eng Eong (Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore)
[S2-2]Establishment of a simple high-speed reverse genetics system for SARS-CoV-2
○Takasuke Fukuhara(Department of Microbiology and Immunology, Graduate School of medicine, Hokkaido University)
[S2-3]Revealing pathogenesis mechanisms of Severe fever with thrombocytopenia syndrome virus infection through the SFTSV-B cell axis
○Tadaki Suzuki(Department of Pathology, National Institute of Infectious Diseases)
[S2-4]Exploring the interaction between the highly pathogenic viruses and small chemical compounds: for the better understanding of the virus replication mechanism
○Shuzo Urata(National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, Nagasaki, Japan)
[S3-1]A GWAS approach reveals putative bacterial risk factors for cavitary Mycobacterium avium complex lung disease
○Hirokazu Yano1, Yukiko Nishiuchi1, Arikawa Kentaro3, Atsushi Ota4, Mari Miki5, Fumito Maruyama4, Hiroshi Kida5, Seigo Kitada5, Tomotada Iwamoto3(1.Graduate School of Life Sciences, Tohoku University, Seandai, Japan, 2.Graduate School of Medicine, Osaka City University, Osaka, Japan, 3.Kobe Institute of Health, Kobe, Japan, 4.Office of Industry-Academia-Government and Community Collaboration, Hiroshima University, Higashihiroshima, Japan, 5.National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan)
[S3-2]In silico Drug Discovery using the Structural biology Data and Molecular Simulation
○Takatsugu Hirokawa(Division of Biomedical Science, University of Tsukuba, Ibaraki, Japan)
[S3-3]Computational analysis of antibodies and antibody-antigen interactions
○Daisuke Kuroda1,2,3, Kouhei Tsumoto1,2,3,4(1.Medical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Tokyo, Japan, 2.Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan, 3.Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Japan, 4.The Inssisute of Medical Science, The University of Tokyo, Japan)
[S3-4]Direct regulons of AtxA, the master virulence regulator of Bacillus anthracis
○Yoshikazu Furuta1, Cheng Cheng2, Tuvshinzaya Zorigt1, Atmika Paudel1, Shun Izumi1,3, Mai Tsujinouchi1, Tomoko Shimizu1, Wim G Meijer2, Hideaki Higashi1(1.International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 2.UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland, 3.Faculty of Health Sciences, Hokkaido University, Japan)
[S4-1]Memory-type pathogenic Th2 (Tpath2) cells in the pathogenesis of chronic airway inflammation
○Toshinori Nakayama(Chiba University, Chiba, Japan)
[S4-2]Neural Repair after Ischemic Brain Injury by Innate and Adaptive Immunity
○Akihiko Yoshimura1, Ito Minako2(1.Department of Microbiology and Immunology, Keio University School of Medicine, 2.Division of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University, Kyushu University, Fukuoka, Japan)
[S4-3]The biochemical dialog between major physiological systems mediated by immune cells
○Sidonia Fagarasan(Laboratory for Mucosal Immunity, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan)
[S4-4]Gateway Reflex, a molecular mechanism how to establish gateways for autoreactive CD4+ T cells in blood barriers via specific neural activation
○Masaaki Murakami(Division of Molecular Neuroimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan and Group of Quantumimmunology, Institute for Quantum Life Science, QST, Chiba, Japan)
[S5-1]Leishmania exosomes as a vaccine against cutaneous leishmaniasis
○Mayda Gursel(Middle East Technical University, Ankara, Turkey)
[S5-2]Host-Plasmodium interactions: Is sterile immunity against malaria possible?
○Cevayir Coban(Division of Malaria Immunology, IMSUT, University of Tokyo, Japan)
[S5-3]Genetic diversity of Japanese Toxoplasma population based on genome-wide SNP analysis
○Kisaburo Nagamune1,2, Matsuzaki Motomichi1,3(1.Department of Parasitology, National Institute of Infectious Diseases, Tokyo, Japan, 2.Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan, 3.RIKEN Center for Advanced Intelligence Project, Tokyo, Japan)
[S5-4]Hemophagocytosis induced by Leishmania donovani infection is beneficial to parasite survival within macrophages
○Yasuyuki Goto(Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan)
[S6-1]Introduction
○Yoshihiro Kawaoka
[S6-2]Cross-kingdom infection: An alternative route of fungal viruses spread in nature
○Liying Sun(College of Plant Protection, Northwest A&F University, Shaanxi, China)
[S6-3]The emergence of mosquito-borne viral diseases: preparing for the unexpected
○Roy A Hall(The University of Queensland)
[S6-4]Partnership between capsidless (+)ssRNA yadokariviruses and their host dsRNA viruses: Promiscuous or virtuous?
○Nobuhiro Suzuki, Sato Yukiyo(IPSR, Okayama University, Kurashiki, Japan)
[NVS1-1]The Emergence and Ongoing Evolution of SARS-CoV-2
○Edward Holmes(The University of Sydney, Sydney, NSW 2006, Australia.)
[NVS1-2]Investigation of endogenous or symbiotic viruses in hematophagous arthropods
○Hirofumi Sawa1,2, Keita Matsuno1,2, Ryo Nakao3, Michihito Sasaki1, Yasuko Orba1(1.Division of Molecular Pathobiology, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, 2.One Health Research Center, Hokkaido University, 3.Laboratory of Parasitology, Department of Disease Control, Graduate School of Infectious Diseases, Faculty of Veterinary Medicine, Hokkaido University)
[NVS1-3]A strategy for virus survival in nature: the genetic diversity of SARS-CoV-2
○Tokiko Watanabe(Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University)
[NVS1-4]Molecular Mechanisms of Herpes Simplex Virus Infection
○Yasushi Kawaguchi(The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
[NVS2-1]Viruses of hyperthermophilic Archaea: Hottest Topic in Virology (literally)
○Tomohiro Mochizuki(Earth-Life Science Institute (ELSI), Tokyo Institute of Technology, Tokyo, Japan)
[NVS2-2]Are emerging infections caused by morbilliviruses a potential or real threat to humans?
○Makoto Takeda(Department of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan)
[NVS2-3]Detection and functional elucidation of endogenous RNA viruses in the mammalian genomes
○Keizo Tomonaga(Institute for Frontier Life and Medical Sciences, Kyoto University)
[NVS2-4]Endogenous viral elements and their role in antiviral immunity in mosquitoes
○Maria Carla SALEH(Institut Pasteur, Paris, France)
[NVS3-1]Plant viruses: a biological-mechanistic and evolutionary perspective on their default status
○Richard Kormelink(Laboratory of Virology, Department of Plant Sciences, Wageningen University & Research)
[NVS3-2]Acute and persistent plant viruses: novel roles and interactions
○Jesús Navas-Castillo(Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM-CSIC-UMA), Algarrobo-Costa, Malaga, Spain)
[NVS3-3]The Polymycoviridae family: an example of 'neo-viruses'
○Ioly Kotta-Loizou1, Robert H. A. Coutts2(1.Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom, 2.Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom)
[NVS3-4]Cucumber mosaic virus infection in Arabidopsis: a conditional mutualistic symbiont?
○Hideki Takahashi(Graduate School of Agricultural Science, Tohoku University)
[NVS4-1]Protistan Viruses as virulence factors: Discovery of a family of bisegmented Narna-like virus (NLV) in Apicomplexan and Trypanosomatid parasites
○Stephen M. Beverley1, Natalia S. Akopyants1, Asis Kahn1, Lon-Fye Lye1, Siddhartha Krishnamurthy2, Juliana M. Sa3, D Serre4, L. David Sibley1(1.Dept. of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA, 2.Metaorganism Immunity Section, Laboratory of Immune System Biology, NIAID, Bethesda, USA, 3.Laboratory of Malaria and Vector Research, NIAID, Bethesda, USA, 4.Dept. of Microbiology and Immunology, U. Maryland School of Medicine, Baltimore, USA)
[NVS4-2]Co-translational proline hydroxylation is essential for flavivirus biogenesis
○Raul Andino1, Ranen Aviner1,2, Kathy H. Li1, Judith Frydman2(1.Department of Microbiology and Immunology, Unversity of California, San Francisco, USA, 2.Department of Biology and Genetics, Stanford University, Palo Alto, California, USA)
[NVS4-3]The oceans are a vast reservoir of undiscovered diversity of RNA viruses
○Curtis A Suttle1,2,3,4, Marli Vlok3,5, Tianyi Chang1, Junya Hirai6(1.Department of Earth, Ocean & Atmospheric Sciences, University of British Columbia, Vancouver, BC, Canada, 2.Dept of Microbiology & Immunology, University of British Columbia, 1365-2350 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3, 3.Dept of Botany, University of British Columbia, 3156-6270 University Boulevard, Vancouver, BC Canada V6T 1Z4, 4.Institute for the Oceans & Fisheries, AERL, 2202 Main Mall, Vancouver, BC Canada V6T 1Z4, 5.Dept of Biochemistry, University of British Columbia, 2350 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3, 6.Atmosphere and Ocean Research Institute, University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8564, Japan)
[NVS4-4]Neo-virology in aquatic realm
○Keizo Nagasaki1, Ogata Hiroyuki2, Nunoura Takuro3, Tomaru Yuji4, Kimura Kei5, Endo Hisashi2, Urayama Shun-ichi6, Takaki Yoshihiro4(1.Kochi University, Kochi, Japan, 2.Kyoto University, Kyoto, Japan, 3.Japan Agency for Marine-Earth Science and Technology, Yokosuka, Japan, 4.Japan Fisheries Research and Education Agency, Hiroshima, Japan, 5.Saga University, Saga, Japan, 6.University of Tsukuba)
[NVS5-1]Genomic epidemiology identifies emergence and rapid transmission in the United States
○Karthik Gangavarapu(Department of Immunology, The Scripps Research Institute)
[NVS5-2]Evolution of SARS-CoV-2
○Kei Sato1,2(1.Institute of Medical Science, University of Tokyo, 2.CREST, Saitama, Japan)
[NVS5-3]Diversity and evolution of RNA viruses in various environments including our genomes
○So Nakagawa(Department of Molecular Life Science, Tokai University School of Medicine, Kanagawa, Japan)
[NVS5-4]The role of lipids and lipid-associated proteins in assembly of Flaviviridae viruses
Tomokazu Tamura1,2, Torii Shiho1,3,4, Ono Chikako1,3,5, Fukuhara Takasuke1,6, ○Matsuura Yoshiharu1,3(1.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 2.Department of Molecular Biology, Princeton University, NJ, USA, 3.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan, 4.Insect-Virus Interaction Unit, Department of Virology, Institute Pasteur, Paris, France, 5.Laboratory for Cell Polarity Regulation, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan, 6.Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan)
[P-001]Amino acid repeat-containing super-giant protein VP492 may determine the intraspecific host specificity of a dsDNA virus which infects the bloom-forming microalga Heterosigma akashiwo
○Keizo Nagasaki1, Moromoti Daichi2, Takebe Hiroaki2, Hiromoto Haruna1, Takahashi Michiko1, Wada Kei3(1.Faculty of Science and Technology, Kochi University, 2.Kyoto University, Kyoto, Japan, 3.Miyazaki University, Miyazaki, Japan)
[P-002]The role of non-polyadenylated 3'-UTR of LCMV mRNA in translation regulation
○Mei Hashizume, Takashima Ayako, Iwasaki Masaharu(Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan)
94 results ( 1 - 50 )
- 1